_edited.png)
Alcohol Harm Reduction: A Response to "Balance Your Buzz"
Harm reduction is most often applied to drug use, especially opioids. The harm reduction approach includes the widespread distribution of the opioid reversal medication naloxone, fentanyl test strips, and—where legal—access to syringes.
But what about reducing risky alcohol consumption? Most people who drink are not ready to give up alcohol completely. What have we done for them? Right now, virtually nothing.
The distribution of disposable breathalyzers is a brilliant idea and should be seriously considered. Imagine if bars had supplies of these devices available for their patrons. Most bar owners want to be responsible citizens and do not want to see their customers overly intoxicated.
Another effective way to cut down on drinking is through the FDA-approved anticraving medication naltrexone. The use of naltrexone to reduce drinking is popularized by an approach called The Sinclair Method. There is a lot of good information about this method available online.
Alcohol misuse is a far bigger problem than opioid addiction, yet we have not spent nearly as much time and resources addressing this issue.
Want to connect with Percy? Reach out to him on LinkedIn
This is such an important take — the breathalyzer distribution idea feels like a simple yet genuinely practical way to meet students where they are. Thanks for highlighting what’s been missing in alcohol harm reduction.
This is a thoughtful response, Percy. The disposable breathalyzer idea is such a practical and non-judgmental way to bring harm reduction to everyday drinkers—something we don’t talk about enough. Thanks for shedding light on this gap.
Thanks for making the case for alcohol harm reduction – the breathalyzer idea is a great example of meeting people where they are, without requiring them to quit entirely.
This article raises an important point about alcohol harm reduction—tools like breathalyzers and naltrexone deserve way more attention. Just like finding your balance on tricky terrain in Blocky Xtreme, managing drinking takes practice and the right support!
Interesting update on Monopar Therapeutics’ IPO announcement. It’s always insightful to follow developments in the biotech and healthcare sector. Wishing them success ahead. I also share informative and positive updates like this on my platform Happy Mode App.